Swiss National Bank’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-209,486	Closed	-$274K	–	2559
2019 Q1	$274K	Buy	209,486 +45,200	+28%	+$56.2K	﹤0.01%	2470
2018 Q4	$150K	Sell	164,286 -23,493	-13%	-$36K	﹤0.01%	2530
2018 Q3	$386K	Hold	187,779	–	–	﹤0.01%	2455
2018 Q2	$338K	Hold	187,779	–	–	﹤0.01%	2497
2018 Q1	$442K	Buy	187,779 +22,517	+14%	+$52.8K	﹤0.01%	2404
2017 Q4	$311K	Buy	165,262 +38,862	+31%	+$84.9K	﹤0.01%	2487
2017 Q3	$314K	Hold	126,400	–	–	﹤0.01%	2478
2017 Q2	$348K	Hold	126,400	–	–	﹤0.01%	2498
2017 Q1	$382K	Buy	126,400 +19,888	+19%	+$56.5K	﹤0.01%	2444
2016 Q4	$336K	Hold	106,512	–	–	﹤0.01%	2498
2016 Q3	$363K	Hold	106,512	–	–	﹤0.01%	2438
2016 Q2	$243K	Buy	106,512 +26,959	+34%	+$66.1K	﹤0.01%	2542
2016 Q1	$191K	Buy	79,553 +14,629	+23%	+$32.6K	﹤0.01%	2560
2015 Q4	$215K	Hold	64,924	–	–	﹤0.01%	2565
2015 Q3	$157K	Buy	64,924 +10,407	+19%	+$26.9K	﹤0.01%	2523
2015 Q2	$160K	Buy	+54,517	New	+$211K	﹤0.01%	2559
2014 Q2	–	Sell	-35,188	Closed	-$93K	–	2540
2014 Q1	$93K	Buy	35,188 +12,266	+54%	+$36.1K	﹤0.01%	2483
2013 Q4	$67K	Hold	22,922	–	–	﹤0.01%	2500
2013 Q3	$70K	Hold	22,922	–	–	﹤0.01%	2473
2013 Q2	$73K	Buy	+22,922	New	+$73.4K	﹤0.01%	2490

Other funds holding LCTX